The Senate Special Committee on Aging convened a hearing to discuss the impact of quality issues in imported generic drugs and active pharmaceutical ingredients (APIs). This hearing focused on describing concerns about the generic drug supply and the Committee plans to hold a subsequent hearing to discuss solutions.   Opening Statements: Chair Rick Scott (R-FL) highlighted his concerns about the national security and drug… (McClurg, June 4, 2026) #Biosimilars, #Generic Drugs, #Quality